Article

Law to Regulate PBMs Tops AJPB Week in Review

Top news of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Food and Drug Administration (FDA) is a federal agency of the Department of Health and Human Services. The concept of rejection of new medications, vaccines and biopharmaceuticals by the FDA
July 11th 2025

FDA Publishes Hundreds of Complete Response Letters From First Half of the Decade

Luke Halpern, Assistant Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models
July 10th 2025

Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models

Aislinn Antrim, Managing Editor
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Medical form, diagnosis schizophrenia | Image Credit: Rawf8 | stock.adobe.com
July 10th 2025

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Danielle Valletti, Assistant Editor
Abstract representation of cholesterol levels with colorful particles floating. This illustrates complexity of blood components and cholesterol
July 10th 2025

With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided

Luke Halpern, Assistant Editor